Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Key Events This Week: Payrolls, CPI And Retail Sales (ZeroHedge) +++ NVIDIA Aktie +3,63%

INNOVENT BIOLOGICS Aktie

 >INNOVENT BIO Aktienkurs 
9.25 EUR    +4.5%    (Tradegate)
Ask: 9.25 EUR / 539 Stück
Bid: 9 EUR / 557 Stück
Tagesumsatz: 562 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
INNOVENT BIO Aktie über LYNX handeln
>INNOVENT BIO Performance
1 Woche: 0%
1 Monat: -5,9%
3 Monate: -9,7%
6 Monate: -16,7%
1 Jahr: +100,6%
laufendes Jahr: +1,4%
>INNOVENT BIOLOGICS Aktie
Name:  INNOVENT BIOLOGICS INC.
Land:  China
Sektor:  Gesundheit
ISIN/ Wkn:  KYG4818G1010 / A2N7N8
Symbol/ Ticker:  6IB (Frankfurt)
Kürzel:  FRA:6IB, ETR:6IB, 6IB:GR
Index:  -
Webseite:  http://cn.innoventbio.com..
Profil:  Innovent Biologics Inc. engages in the research, d..
>Volltext..
Marktkapitalisierung:  15012.26 Mio. EUR
Unternehmenswert:  14287.75 Mio. EUR
Umsatz:  1328.84 Mio. EUR
EBITDA:  261.34 Mio. EUR
Nettogewinn:  131.44 Mio. EUR
Gewinn je Aktie:  0.08 EUR
Schulden:  401.95 Mio. EUR
Liquide Mittel:  1126.57 Mio. EUR
Operativer Cashflow:  252.84 Mio. EUR
Bargeldquote:  1.9
Umsatzwachstum:  38.19%
Gewinnwachstum:  -
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  INNOVENT BIOLOGICS, INNOVENT BIO
Letzte Datenerhebung:  09.02.26
>INNOVENT BIO Kennzahlen
Aktien/ Unternehmen:
Aktien: 1735.19 Mio. St.
Frei handelbar: 89.99%
Leerverk. Aktien: -
Rückkaufquote: -0.06%
Mitarbeiter: 5659
Umsatz/Mitarb.: 0.2 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 43.82%
Bewertung:
KGV: 111.45
KGV lG: 122.13
KUV: 11.63
KBV: 8.47
PEG-Ratio: -
EV/EBITDA: 54.67
Rentabilität:
Bruttomarge: 85.41%
Gewinnmarge: 9.89%
Operative Marge: 15.4%
Managementeffizenz:
Gesamtkaprendite: 5.12%
Eigenkaprendite: 8.37%
>INNOVENT BIO Peer Group
Gesundheit, Autoimmunerkrankungen, Onkologie/ Krebs- Behandlung
 
09.02.26 - 07:00
Innovent Biologics Strikes Partnership Deal With Eli Lilly (WSJ EN)
 
Chinese drugmaker Innovent Biologics and Eli Lilly plan to target cancer and immune system diseases under the partnership....
09.02.26 - 05:39
Innovent Biologics shares surge on $350 mln Eli Lilly partnership (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
09.02.26 - 05:15
Research: G Sachs Rates INNOVENT BIO as Buy on Deepened Long-term Partnership w/ Eli Lilly (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
09.02.26 - 04:48
Lilly Inks Deal with Innovent to Speed Up Early Drug Development (Bloomberg)
 
Eli Lilly & Co. is paying $350 million upfront to collaborate with Chinese biotech Innovent Biologics Inc. in developing new treatments for cancer and immune disorders, a further vote of confidence for the innovation capabilities of the country's drugmakers....
09.02.26 - 04:15
Research: BofAS Keeps Buy on INNOVENT BIO w/ TP HKD113.5 (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
09.02.26 - 04:00
Research: CICC: INNOVENT BIO Innovation Drives Strong Results Growth; 2026 Earnings Forecast Raised (AAStocks)
 
INNOVENT BIO (01801.HK) forecasted a 2025 product revenue of approx. RMB11.9 billion, up about 45% YoY, according to CICC's research report. Of which, 4Q25 product revenue amounted to approx. RMB3.3 billion, up over 60% YoY, in line with CICC's expectations.Taking into account the impact of the 2026 Takeda collaboration,......
09.02.26 - 03:45
INNOVENT BIO Swells ~6% on Global Strategic Collaboration with Eli Lilly (AAStocks)
 
INNOVENT BIO (01801.HK) opened nearly 4.7% higher this morning, and swelled 5.9% to $84.2 in the morning session. Trading volume was 3.895 million shares, involving $330 million. The Company entered into a global strategic collaboration with Eli Lilly and Company (LLY.US) to advance novel medicines in oncology and immunology.INN......
09.02.26 - 03:12
Hong Kong stocks start week strong on sentiment stabilisation, Japan election (SCMP)
 
Hong Kong stocks rose alongside other markets in Asia, as sentiment towards global risk assets stabilised and the victory of Japan's ruling party in the parliamentary election boosted risk appetite. The Hang Seng Index added 1.3 per cent to 26,913.07 as of 9.52am local time. The Hang Seng Tech Index gained 1.1 per cent. On the mainland, the CSI 300 Index climbed 1 per cent and the Shanghai Composite Index rose 0.9 per cent. Biotech firm Innovent Biologics surged almost 5 per cent to HK$83.25,......
09.02.26 - 02:42
Innovent And Lilly Expand Collaboration To Advance Global Oncology & Immunology Drugs (AFX)
 
INDIANAPOLIS (dpa-AFX) - Innovent Biologics Inc. (IVBXF, 1801.HK) announced a new strategic collaboration with Eli Lilly and Company. This marks the seventh partnership between the two companies, ......
08.02.26 - 11:09
Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology (PR Newswire)
 
SAN FRANCISCO and SUZHOU, China, Feb. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and......
27.01.26 - 01:03
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma (PR Newswire)
 
SAN FRANCISCO and SUZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and......
13.01.26 - 04:15
Research: UBS: INNOVENT BIO Maintains 2027 Sales Target; Rating Buy (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
09.01.26 - 01:01
Innovent′s Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration (PR Newswire)
 
SAN FRANCISCO and SUZHOU, China, Jan. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and......
05.01.26 - 05:45
Research: Daiwa Names INNOVENT BIO as Top Pick Alongside HENGRUI PHARMA w/ TP Lifted to HKD112 (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
31.12.25 - 08:00
Outlook: CCBI, SPDBI′s Top Picks for Hong Kong Stocks (Table) (AAStocks)
 
CCBI released a report in early December, outlining its top ten focus stocks for 2026:CCBI's Top Ten Focus Stocks for 2026BABA-W (09988.HK)TENCENT (00700.HK)SMIC (00981.HK)SANHUA (02050.HK)COMEC (00317.HK)INNOVENT BIO (01801.HK)CTG DUTY-FREE (01880.HK)YUM CHINA (09987.HK)LEAPMOTOR (09863.HK)CITIC BANK (00998.HK)-------------......
31.12.25 - 07:45
Review: HSCEI Top 5 Strongest & Weakest Stocks in 2025 (Table) (AAStocks)
 
HSCEI Top 5 Strongest Stocks in 2025:Stock | Change in Shr Price This YrCHINAHONGQIAO (01378.HK) | +177.4%ZIJIN MINING (02899.HK) | +152.2%SMIC (00981.HK) | +124.7%POP MART (09992.HK) | +109.4%INNOVENT BIO (01801.HK) | +108.3%HSCEI Top 5 Weakest Stocks in 2025:Stock | Change in Shr Price This YrMEITUAN-W (03690.HK) | -31.9%LI AU......
31.12.25 - 05:30
Midday Takeaway: HSI Closes Midday at 25,630, Down 224 pts; HSTI Closes Midday at 5,515, Down 62 pts; INNOVENT BIO Down over 3%; JIANGXI COPPER Hit New Highs (AAStocks)
 
At midday close, HSI dropped 224 pts or 0.9% to 25,630. HSTI dropped 62 pts or 1.1% to 5,515. HSCEI fell 77 pts or 0.9% to 8,913.Active Heavyweights:PING AN (02318.HK) closed at $65.15, down 1.2%BABA (09988.HK) closed at $142.8, down 1.2%MEITUAN (03690.HK) closed at $103.3, down 1%CCB (00939.HK) closed at $7.69, down 0.4%TENCENT......
19.12.25 - 04:15
Research: JPM Sees CN Healthcare Sector Pullback as Entry Opportunity, Raises TPs for INNOVENT BIO/ WUXI XDC (AAStocks)
 
According to JPMorgan's research report, while the Chinese healthcare sector retreated from its highs in September and October due to the results of the national medical insurance drug list price negotiations and subsequent profit-taking, the broker believes the industry's fundamentals remain unchanged, and the recent we......
18.12.25 - 01:03
Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature (PR Newswire)
 
SAN FRANCISCO and SUZHOU, China, Dec. 17, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and......
10.12.25 - 01:30
Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody (PR Newswire)
 
SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic,......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Häuser von Rechtsanwälten werden auf den Köpfen von Idioten erbaut. - George Herbert
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!